Three-Dimensional Transjugular Intrahepatic Portosystemic Shunt Geometry Predicts Shunt Dysfunction
- PMID: 40202365
- PMCID: PMC12074561
- DOI: 10.1111/apt.70133
Three-Dimensional Transjugular Intrahepatic Portosystemic Shunt Geometry Predicts Shunt Dysfunction
Abstract
Background: Patients with decompensated cirrhosis are at risk of portal hypertension-related complications, such as refractory ascites or variceal bleeding. Transjugular intrahepatic portosystemic shunt (TIPS) insertion is the most effective treatment to reduce portal hypertension. However, patients are at risk for TIPS dysfunction.
Aims: We aimed to investigate the prognostic value of three-dimensional (3D) TIPS geometry in predicting TIPS dysfunction.
Methods: A total of 107 patients who underwent TIPS insertion between 2014 and 2019 and received a computed tomography (CT) scan after TIPS insertion during routine clinical practice were included. We used a semiautomated algorithm and multiplanar reconstructions of these CT scans to calculate parameters of 3D TIPS geometry. The primary outcome of this study was the development of TIPS dysfunction (defined as need for invasive TIPS revision). To identify predictors for the development of TIPS dysfunction, Cox regression analyses were performed with TIPS dysfunction as the endpoint.
Results: Thirty-two patients developed TIPS dysfunction and were compared to the dysfunction-free 75 patients. A larger distance from the cranial TIPS stent end to the vena cava inferior (p < 0.001, HR 1.061, 95% CI 1.030-1.093) and the maximum stent curvature (p = 0.003, HR 1.020, 95% CI 1.007-1.034) were significantly associated with TIPS dysfunction in a multivariate Cox regression analysis.
Conclusion: A more pronounced stent curvature and a longer cranial stent distance from the inferior vena cava were identified as independent predictors of TIPS dysfunction. Interventionalists should choose a more central and less curved TIPS tract during the TIPS procedure to reduce the risk of development of TIPS dysfunction.
Trial registration: This retrospective monocentric study includes patients from the NEPTUN cohort (registered at ClinicalTrials.gov; Identifier: NCT03628807).
Keywords: cirrhosis; portal hypertension; transjugular intrahepatic portosystemic shunt.
© 2025 The Author(s). Alimentary Pharmacology & Therapeutics published by John Wiley & Sons Ltd.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures


Similar articles
-
Long-term effects and complications of the transjugular intrahepatic portosystemic shunt: a single-centre experience.Scand J Gastroenterol. 2019 Jul;54(7):899-904. doi: 10.1080/00365521.2019.1630675. Epub 2019 Jun 16. Scand J Gastroenterol. 2019. PMID: 31203699
-
Long-term clinical outcome and survival predictors in patients with cirrhosis after 10-mm-covered transjugular intrahepatic portosystemic shunt.Gastroenterol Hepatol. 2021 Nov;44(9):620-627. doi: 10.1016/j.gastrohep.2020.10.018. Epub 2020 Nov 26. Gastroenterol Hepatol. 2021. PMID: 33249114 English, Spanish.
-
CXCL9 is a prognostic marker in patients with liver cirrhosis receiving transjugular intrahepatic portosystemic shunt.J Hepatol. 2015 Feb;62(2):332-9. doi: 10.1016/j.jhep.2014.09.032. Epub 2014 Oct 17. J Hepatol. 2015. PMID: 25457205
-
The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension.J Clin Gastroenterol. 2007 Nov-Dec;41 Suppl 3:S344-51. doi: 10.1097/MCG.0b013e318157e500. J Clin Gastroenterol. 2007. PMID: 17975487 Review.
-
Transjugular intrahepatic portosystemic shunt in patients with cirrhosis: Indications and posttransjugular intrahepatic portosystemic shunt complications in 2020.United European Gastroenterol J. 2021 Mar;9(2):203-208. doi: 10.1177/2050640620952637. Epub 2021 Feb 23. United European Gastroenterol J. 2021. PMID: 32819214 Free PMC article. Review.
References
-
- Rössle M., “TIPS: 25 Years Later,” Journal of Hepatology 59 (2013): 1081–1093. - PubMed
-
- Angeli P., Bernardi M., Villanueva C., et al., “EASL Clinical Practice Guidelines for the Management of Patients With Decompensated Cirrhosis [Internet],” Journal of Hepatology 69 (2018): 406–460. - PubMed
-
- García‐Pagán J. C., Caca K., Bureau C., et al., “Early Use of TIPS in Patients With Cirrhosis and Variceal Bleeding,” New England Journal of Medicine 362 (2010): 2370–2379. - PubMed
-
- Bureau C., Thabut D., Oberti F., et al., “Transjugular Intrahepatic Portosystemic Shunts With Covered Stents Increase Transplant‐Free Survival of Patients With Cirrhosis and Recurrent Ascites,” Gastroenterology 152 (2017): 157–163. - PubMed
MeSH terms
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Medical